?We have been exploring opportunities? | Latest News India - Hindustan Times
close_game
close_game

?We have been exploring opportunities?

None | BySuprrotip Ghosh, Mumbai
Mar 30, 2006 01:23 PM IST

Malvviinder Singh of Ranbaxy speaks to Suprrotip Ghosh about Terapia.

Malvviinder Singh of Ranbaxy spoke to Suprrotip Ghosh about Terapia:

HT Image
HT Image

How were you involved in the deal?

Unlock exclusive access to the latest news on India's general elections, only on the HT App. Download Now! Download Now!

After taking up at the helm, I initiated the company’s inorganic expansion plan. Accordingly we took board and shareholder approval to raise equity and debt in an enabling provision. We have been exploring opportunities worldwide, and when the deal came through, we sealed it.

Why Terapia and no other company?

Terapia is the best in Romania. It is the largest independent generics company in the country. It has one of the two bioequivalence study centres in Romania. They are also the largest exporters of generics into CIS countries, including Russia, Ukraine and Poland. Besides, it has got a great team on the ground.

What are the synergies and plans for Terapia?

We need to increase capacities in R&D, and also in bio-equivalence studies. There is need to increase manufacturing facilities. We have to integrate Ranbaxy’s operations in Romania with Terapia.

Tell us what your First Vote will stand for in a short video & get a chance to be featured on HT’s social media handles. Click here to know more!

Get Current Updates on India News, Elections 2024, Lok Sabha Election 2024 Live, Election 2024 Date, Weather Today along with Latest News and Top Headlines from India and around the world.
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Thursday, May 23, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On